When it comes to men’s health, tadalafil is one of the most talked-about medications out there. Originally developed to treat ...
with adenocarcinoma of the prostate (Gleason ≤ 7, normal preoperative erectile function [EF]) were randomized post-nsRP 1:1:1 to 9-month treatment with tadalafil 5 mg OaD, tadalafil 20 mg ...
i.e., the presence of BPH reduced improvement during tadalafil OaD treatment. However, BPH can be accompanied by other comorbidities and the estimated reduction in efficacy from our model is ...
Tadalafil is a vasodilator, meaning it improves blood flow throughout your body, including to the tissue of your privates. But this medication is also used to treat symptoms of BPH (benign ...
Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...
Opella reaches study milestone for CialisParis, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and ...